These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10153138)

  • 1. Avoiding antitrust snags requires forethought and thorough market analysis.
    Engstrom P
    Med Netw Strategy Rep; 1995 May; 4(5):1-4. PubMed ID: 10153138
    [No Abstract]   [Full Text] [Related]  

  • 2. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis in health care antitrust.
    Vita MG; Langenfeld J; Pautler P; Miller L
    J Contemp Health Law Policy; 1991; 7():73-115. PubMed ID: 10111250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Much ado about networks.
    Greaney TL
    J Health Hosp Law; 1996 Dec; 29(5):307-11. PubMed ID: 10164237
    [No Abstract]   [Full Text] [Related]  

  • 5. Health care collaboration, antitrust, and the 1992 merger guidelines: do competition and cost effective co-operation conflict?
    Adler H
    J Health Hosp Law; 1992 Jul; 25(7):193-200. PubMed ID: 10123591
    [No Abstract]   [Full Text] [Related]  

  • 6. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
    Wright R
    J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitrust and affiliations among healthcare providers: the need for a level playing field.
    Heightchew A
    Hosp Health Serv Adm; 1997; 42(4):559-65. PubMed ID: 10174466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarify antitrust laws: AHA. Group discusses benefits of clinical integration practices.
    DoBias M
    Mod Healthc; 2007 Apr; 37(17):12. PubMed ID: 17477193
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust issues for hospice agencies.
    Mattson CW
    Caring; 1995 Nov; 14(11):43-5, 49-52. PubMed ID: 10154896
    [No Abstract]   [Full Text] [Related]  

  • 10. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

  • 11. Networks can avoid antitrust scrutiny.
    Waxman JM
    Provider; 1997 Feb; 23(2):42-5. PubMed ID: 10167120
    [No Abstract]   [Full Text] [Related]  

  • 12. More on integrated delivery systems.
    Meier MH
    N Engl J Med; 2010 Apr; 362(13):1247-8. PubMed ID: 20357293
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitrust in the health services industry: the first five years.
    Dolan AK
    Health Med Care Serv Rev; 1981-1982; 3(2-3):13, 15-24. PubMed ID: 10299261
    [No Abstract]   [Full Text] [Related]  

  • 14. PPOs and the antitrust laws.
    Stromberg RE; Duncheon MA; Goldman JS
    Hospitals; 1983 Oct; 57(20):65-70. PubMed ID: 6618473
    [No Abstract]   [Full Text] [Related]  

  • 15. Government agencies soften stance on what constitutes price fixing.
    Ettinger DA; Lasser ML
    Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating antitrust risk in joint provider negotiations with payors.
    Leonard EJ
    Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Supreme Court, antitrust and the health care field.
    Health Law Vigil; 1982 Oct; 5(22):1-14. PubMed ID: 10257142
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
    Ewing KP; Koslov TI
    Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
    [No Abstract]   [Full Text] [Related]  

  • 19. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
    Marx D; Busey RC
    J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
    [No Abstract]   [Full Text] [Related]  

  • 20. COPAing with antitrust rules. Just three systems have used certificates of public advantage seeking antitrust immunity. Experts now say they're regulatory dinosaurs.
    Taylor M
    Mod Healthc; 2005 Feb; 35(8):30-2, 34. PubMed ID: 15765844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.